CervoMed, Inc. (CRVO)
3.89
+0.01
(+0.26%)
USD |
NASDAQ |
Apr 27, 15:45
CervoMed EPS Diluted (Quarterly) : -0.874 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Agenus, Inc. | -0.301 |
| Curis, Inc. | 1.229 |
| LadRx Corp. | -1.453 |
| Plus Therapeutics, Inc. | -1.03 |
| Windtree Therapeutics, Inc. | -1.085 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -8.087M |
| Revenue (Quarterly) | 0.0087M |
| Total Expenses (Quarterly) | 8.096M |
| Enterprise Value | 15.06M |
| Profit Margin (Quarterly) | -92.96K% |
| Earnings Yield | -76.37% |
| Normalized Earnings Yield | -76.37 |